Growth pattern and pubertal development in patients with classic 21-hydroxylase deficiency

1. Speiser PW, White PC. Congenital adrenal hyperplasia. N Engl J Med. 2003; 349:776-88.10.1056/NEJMra021561Search in Google Scholar

2. Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine clinical practice guideline. J Clin Endocrinol Metab. 2010; 95:4133-60.10.1210/jc.2009-2631Search in Google Scholar

3. Soliman AT, AlLamki M, AlSalmi I, Asfour M. Congenital adrenal hyperplasia complicated by central precocious puberty: linear growth during infancy and treatment with gonadotropin-releasing hormone analog. Metabolism. 1997; 46:513-7.10.1016/S0026-0495(97)90186-4Search in Google Scholar

4. Muirhead S, Sellers EA, Guyda H. Indicators of adult height outcome in classical 21-hydroxylase deficiency congenital adrenal hyperplasia. J Pediatr. 2002; 141: 247-52.10.1067/mpd.2002.12660112183722Search in Google Scholar

5. Eugster EA, Dimeglio LA, Wright JC, Freidenberg GR, Seshadri R, Pescovitz OH. Height outcome in congenital adrenal hyperplasia caused by 21- hydroxylase deficiency: a meta-analysis. J Pediatr. 2001; 138:26-3210.1067/mpd.2001.11052711148508Search in Google Scholar

6. Bonfig W, Bechtold S, Schmidt H, Knorr D, Schwarz HP. Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty. J Clin Endocrinol Metab. 2007; 92:1635-910.1210/jc.2006-210917299071Search in Google Scholar

7. Trinh L, Nimkarn S, New MI, Lin-Su K. Growth and pubertal characteristics in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Pediatr Endocrinol Metab. 2007; 20:883-91Search in Google Scholar

8. Muthusamy K, Elamin MB, Smushkin G, Murad MH, Lampropulos JF, Elamin KB, et al. Clinical review: Adult height in patients with congenital adrenal hyperplasia: a systematic review and metaanalysis. J Clin Endocrinol Metab. 2010; 95:4161-72.10.1210/jc.2009-261620823467Search in Google Scholar

9. Somboonnithiphol K, Panamonta O, Kiatchoosakun P, Jirapradittha J, Panamonta M, Lumbiganon P, et al. Newborn screening for congenital adrenal hyperplasia in Srinagarind Hospital, Khon Kaen University, Thailand. Asian Biomed. 2011; 5:855-9.Search in Google Scholar

10. Wacharasindhu S, Supornsilchai V, Aroonparkmongkol S, Sahakitrungrueng T. Pubertal growth in normal Thai children: a longitudinal study. Asian Biomed. 2010; 4:793-5.10.2478/abm-2010-0103Search in Google Scholar

11. Manoli I, Kanaka-Gantenbein CH, Voutetakis A, Maniati-Christidi M, Dacou-Voutetakis C. Early growth, pubertal development, body mass index and final height of patients with congenital adrenal hyperplasia: factors influencing the outcome. Clinical Endocrinology. 2002; 57:669-76.10.1046/j.1365-2265.2002.01645.x12390343Search in Google Scholar

12. Janejai N, Krasao P, Phansang J, Pankarnjanato R, Charoensiriwatana W. Congenital adrenal hyperplasia: should nationwide screening be implemented in Thailand? Southeast Asian J Trop Med Public Health. 2003; 34 Suppl 3:170-3.Search in Google Scholar

13. Bonfig W, Pozza SB, Schmidt H, Pagel P, Knorr D, Schwarz HP. Hydrocortisone dosing during puberty in patients with classical congenital adrenal hyperplasia: an evidence-based recommendation. J Clin Endocrinol Metab. 2009; 94:3882-8.10.1210/jc.2009-094219622620Search in Google Scholar

14. Mikhail G. Hormone secretion by the human ovaries. Gynecol Invest. 1970; 1:5-20.10.1159/000301902Search in Google Scholar

15. Miller WL, Auchus RJ. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev. 2011; 32:81-151.10.1210/er.2010-0013Search in Google Scholar

16. Scholler R, Nahoul K, Castanier M, Rotman J, Salat- Baroux J. Testicular secretion of conjugated and unconjugated steroids in normal adults and in patients with varicocele. Baseline levels and timecourse response to hCG administration. J Steroid Biochem. 1984; 20:203-15.10.1016/0022-4731(84)90207-3Open DOISearch in Google Scholar

17. Völkl TM, Simm D, Beier C, Dörr HG. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics. 2006; 117:e98-105.10.1542/peds.2005-100516396852Search in Google Scholar

18. Finkielstain GP, Kim MS, Sinaii N, Nishitani M, Van Ryzin C, Hill SC, et al. Clinical Characteristics of a Cohort of 244 Patients with Congenital Adrenal Hyperplasia. J Clin Endocrinol Metab. 2012; 97: 4429-38.10.1210/jc.2012-2102351354222990093Search in Google Scholar

19. Lin-Su K, Vogiatzi MG, Marshall I, Harbison MD, Macapagal MC, Betensky B, et al. Treatment with growth hormone and luteinizing hormone releasing hormone analog improves final adult height in children with congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2005; 90:3318-25.10.1210/jc.2004-212815797962Search in Google Scholar

20. Longui CA, Kochi C, Calliari LE, Modkovski MB, Soares M, Alves EF, et al. Near-final height in patients with congenital adrenal hyperplasia treated with combined therapy using GH and GnRHa. Arq Bras Endocrinol Metabol. 2011; 55:661-4.10.1590/S0004-2730201100080002322218451Search in Google Scholar